This finding is further confirmed by previous studies that IL-1 impairs context-associated fear memory (Goshen et al., 2007) and IL-1 receptor antagonist is protective against the hippocampus-dependent cognitive deficits induced by systemic lipopolysaccharide (LPS) administration (Terrando et al., 2010). This evidence concerns the gene IL1B and Cognitive impairment.